VIS649

· Visterra, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for VIS649, covering 2024-11-21 to 2025-03-20. Get the full timeline:

Most recent: Clinical Trial Update: First in Human Study to Assess Safety of VIS649 in Healthy Subjects [Phase 1]